Paula M. Loria

5.0k total citations · 1 hit paper
35 papers, 3.5k citations indexed

About

Paula M. Loria is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Paula M. Loria has authored 35 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Genetics. Recurrent topics in Paula M. Loria's work include Receptor Mechanisms and Signaling (5 papers), Muscle Physiology and Disorders (4 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Paula M. Loria is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Muscle Physiology and Disorders (4 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Paula M. Loria collaborates with scholars based in United States, Australia and Italy. Paula M. Loria's co-authors include Geoffrey L. Greene, Peter J. Kushner, David A. Agard, Lin Cheng, Andrew K. Shiau, Oliver Hobert, Nicola Carulli, Jonathan Hodgkin, Amedeo Lonardo and Thomas A. Brown and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Paula M. Loria

35 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen

1998 2.2k citations Paula M. Loria et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula M. Loria United States	21	1.9k	1.7k	466	452	437	35	3.5k
K.W. Nettles United States	30	1.5k 0.8×	1.2k 0.7×	431 0.9×	218 0.5×	392 0.9×	54	2.9k
Ching‐yi Chang United States	37	2.5k 1.3×	1.8k 1.1×	189 0.4×	560 1.2×	785 1.8×	69	4.8k
Anders Ström Sweden	36	2.4k 1.3×	2.9k 1.7×	226 0.5×	701 1.6×	1.5k 3.4×	68	5.4k
Scott W. Rowlinson United States	30	1.3k 0.7×	536 0.3×	173 0.4×	454 1.0×	329 0.8×	55	3.7k
Lars Öhman United States	10	1.6k 0.8×	2.3k 1.4×	419 0.9×	569 1.3×	475 1.1×	12	3.4k
Atul Purohit United Kingdom	41	2.4k 1.3×	2.6k 1.5×	203 0.4×	738 1.6×	549 1.3×	102	4.7k
Carlotta Granchi Italy	32	2.3k 1.2×	365 0.2×	331 0.7×	202 0.4×	630 1.4×	109	4.1k
Aaron B. Miller United States	26	1.5k 0.8×	640 0.4×	236 0.5×	148 0.3×	485 1.1×	47	2.8k
Chris P. Miller United States	31	1.3k 0.7×	928 0.5×	240 0.5×	308 0.7×	596 1.4×	62	3.5k
Jonna Frasor United States	33	2.2k 1.2×	1.9k 1.1×	126 0.3×	342 0.8×	1.3k 3.1×	71	4.1k

Countries citing papers authored by Paula M. Loria

Since Specialization

Citations

This map shows the geographic impact of Paula M. Loria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula M. Loria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula M. Loria more than expected).

Fields of papers citing papers by Paula M. Loria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula M. Loria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula M. Loria. The network helps show where Paula M. Loria may publish in the future.

Co-authorship network of co-authors of Paula M. Loria

This figure shows the co-authorship network connecting the top 25 collaborators of Paula M. Loria. A scholar is included among the top collaborators of Paula M. Loria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula M. Loria. Paula M. Loria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jové, Veronica, Heather E. Wheeler, David R. Healy, et al.. (2024). Type I interferon regulation by USP18 is a key vulnerability in cancer. iScience. 27(4). 109593–109593. 6 indexed citations

McCorvie, Thomas J., Paula M. Loria, Meihua Tu, et al.. (2022). Molecular basis for the regulation of human glycogen synthase by phosphorylation and glucose-6-phosphate. Nature Structural & Molecular Biology. 29(7). 628–638. 17 indexed citations

Chang, Aaron Y., P. Ya. Tishchenko, Heather Wheeler, et al.. (2021). Modulation of SF3B1 in the pre-mRNA spliceosome induces a RIG-I-dependent type I IFN response. Journal of Biological Chemistry. 297(5). 101277–101277. 11 indexed citations

Vincent, Fabien, Paula M. Loria, Andrea D. Weston, et al.. (2020). Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies. Cell chemical biology. 27(11). 1332–1346. 29 indexed citations

Londregan, Allyn T., Gary E. Aspnes, Chris Limberakis, et al.. (2018). Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3685–3688. 10 indexed citations

Lintner, Nathanael G., Kim F. McClure, Donna N. Petersen, et al.. (2017). Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. PLoS Biology. 15(3). e2001882–e2001882. 94 indexed citations

Plisson, Fabien, Timothy A. Hill, Huy N. Hoang, et al.. (2016). Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling. European Journal of Medicinal Chemistry. 127. 703–714. 20 indexed citations

Swedberg, Joakim E., Christina I. Schroeder, David P. Fairlie, et al.. (2016). Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro. Journal of Biological Chemistry. 291(30). 15778–15787. 8 indexed citations

Futatsugi, Kentaro, Joel T. Arcari, Kevin B. Bahnck, et al.. (2016). Optimization of amide-based EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(11). 2670–2675. 5 indexed citations

10.

Swedberg, Joakim E., Christina I. Schroeder, Thomas Durek, et al.. (2015). Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists. European Journal of Medicinal Chemistry. 103. 175–184. 21 indexed citations

11.

Futatsugi, Kentaro, David W. Piotrowski, Agustin Casimiro‐Garcia, et al.. (2013). Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(23). 6239–6242. 6 indexed citations

12.

Orena, Stephen, Tristan S. Maurer, Li She, et al.. (2013). PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy. Frontiers in Pharmacology. 4. 115–115. 44 indexed citations

13.

Sahasrabudhe, Vaishali, Kevin Sweeney, Meera Tugnait, et al.. (2011). The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism. Journal of Translational Medicine. 9(1). 180–180. 48 indexed citations

14.

Murphy, Kate T., James G. Ryall, Lawrence Nair, et al.. (2010). Antibody-Directed Myostatin Inhibition Improves Diaphragm Pathology in Young but not Adult Dystrophic mdx Mice. American Journal Of Pathology. 176(5). 2425–2434. 46 indexed citations

15.

Pellegrini, Elisa, Mauro Maurantonio, Marco Simonini, et al.. (2010). Risk for cardiovascular events in an Italian population of patients with type 2 diabetes. Nutrition Metabolism and Cardiovascular Diseases. 21(11). 885–892. 14 indexed citations

16.

Carulli, Lucia, et al.. (2005). Review article: diabetes, genetics and ethnicity. Alimentary Pharmacology & Therapeutics. 22(s2). 16–19. 48 indexed citations

17.

Loria, Paula M., Amedeo Lonardo, Lucia Carulli, et al.. (2005). Review article: the metabolic syndrome and non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 22(s2). 31–36. 52 indexed citations

18.

Hobert, Oliver & Paula M. Loria. (2005). Uses of GFP in Caenorhabditis Elegans. Methods of biochemical analysis. 47. 203–226. 20 indexed citations

19.

Loria, Paula M., Jonathan Hodgkin, & Oliver Hobert. (2004). A Conserved Postsynaptic Transmembrane Protein Affecting Neuromuscular Signaling in Caenorhabditis elegans. Journal of Neuroscience. 24(9). 2191–2201. 108 indexed citations

20.

Loria, Paula M., Angie Duke, James B. Rand, & Oliver Hobert. (2003). Two Neuronal, Nuclear-Localized RNA Binding Proteins Involved in Synaptic Transmission. Current Biology. 13(15). 1317–1323. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact